Patent Assignment
Reel/Frame 059817/0193
Assignment of Assignor's Interest
Recorded: 2022-05-04
Pages: 5
Assignors
BOS, MAXENCE
Executed: 2021-05-17
MANCUSO, JOHN
Executed: 2021-05-17
FRANZONI, IVAN
Executed: 2021-05-17
Assignee
NUCHEM THERAPEUTICS INC.
2350 COHEN STREET, SUITE 201, SAINT-LAURENT, QUEBEC, H4R 2N6, CANADA
Covered Property
(1)
Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 4, 2022
From: HOUZE, JONATHAN B.
To: VIGIL NEUROSCIENCE, INC.
Reel/Frame 059816/0877 →
Assignment of Assignor's Interest
May 4, 2022
From: NUCHEM THERAPEUTICS INC.
To: VIGIL NEUROSCIENCE, INC.
Reel/Frame 059817/0240 →
Assignment of Assignor's Interest
May 4, 2022
From: CZABANIUK, LARA C.; HOPPER, TIMOTHY; PANTELEEV, JANE; RESCOURIO, GWENAELLA
To: AMGEN INC.
Reel/Frame 059855/0446 →